Literature DB >> 18467677

Gene profiling in the livers of wild-type and PPARalpha-null mice exposed to perfluorooctanoic acid.

Mitchell B Rosen1, Barbara D Abbott, Douglas C Wolf, J Christopher Corton, Carmen R Wood, Judith E Schmid, Kaberi P Das, Robert D Zehr, Eric T Blair, Christopher Lau.   

Abstract

Health concerns have been raised because perfluorooctanoic acid (PFOA) is commonly found in the environment and can be detected in humans. In rodents, PFOA is a carcinogen and a developmental toxicant. PFOA is a peroxisome proliferator-activated receptor alpha (PPARalpha) activator; however, PFOA is capable of inducing heptomegaly in the PPARalpha-null mouse. To study the mechanism associated with PFOA toxicity, wild-type and PPARalpha-null mice were orally dosed for 7 days with PFOA (1 or 3 mg/kg) or the PPARalpha agonist Wy14,643 (50 mg/kg). Gene expression was evaluated using commercial microarrays. In wild-type mice, PFOA and Wy14,643 induced changes consistent with activation of PPARalpha. PFOA-treated wild-type mice deviated from Wy14,643-exposed mice with respect to genes involved in xenobiotic metabolism. In PFOA-treated null mice, changes were observed in transcripts related to fatty acid metabolism, inflammation, xenobiotic metabolism, and cell cycle regulation. Hence, a component of the PFOA response was found to be independent of PPARalpha. Although the signaling pathways responsible for these effects are not readily apparent, overlapping gene regulation by additional PPAR isoforms could account for changes related to fatty acid metabolism and inflammation, whereas regulation of xenobiotic metabolizing genes is suggestive of constitutive androstane receptor activation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18467677     DOI: 10.1177/0192623308318208

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  26 in total

1.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

2.  Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.

Authors:  Kaberi P Das; Carmen R Wood; Mimi T Lin; Anatoly A Starkov; Christopher Lau; Kendall B Wallace; J Christopher Corton; Barbara D Abbott
Journal:  Toxicology       Date:  2016-12-31       Impact factor: 4.221

Review 3.  Why toxic equivalency factors are not suitable for perfluoroalkyl chemicals.

Authors:  Jeffrey M Peters; Frank J Gonzalez
Journal:  Chem Res Toxicol       Date:  2011-09-28       Impact factor: 3.739

4.  Structure-activity relationships for perfluoroalkane-induced in vitro interference with rat liver mitochondrial respiration.

Authors:  K B Wallace; G E Kissling; R L Melnick; C R Blystone
Journal:  Toxicol Lett       Date:  2013-08-14       Impact factor: 4.372

5.  Peroxisome proliferator-activated receptors alpha, Beta, and gamma mRNA and protein expression in human fetal tissues.

Authors:  Barbara D Abbott; Carmen R Wood; Andrew M Watkins; Kaberi P Das; Christopher S Lau
Journal:  PPAR Res       Date:  2010-07-26       Impact factor: 4.964

6.  Gene Expression Profiling in Wild-Type and PPARα-Null Mice Exposed to Perfluorooctane Sulfonate Reveals PPARα-Independent Effects.

Authors:  Mitchell B Rosen; Judith R Schmid; J Christopher Corton; Robert D Zehr; Kaberi P Das; Barbara D Abbott; Christopher Lau
Journal:  PPAR Res       Date:  2010-09-27       Impact factor: 4.964

7.  Microgram-order ammonium perfluorooctanoate may activate mouse peroxisome proliferator-activated receptor alpha, but not human PPARalpha.

Authors:  Toshiki Nakamura; Yuki Ito; Yukie Yanagiba; Doni Hikmat Ramdhan; Yasuhide Kono; Hisao Naito; Yumi Hayashi; Yufei Li; Toshifumi Aoyama; Frank J Gonzalez; Tamie Nakajima
Journal:  Toxicology       Date:  2009-09-12       Impact factor: 4.221

Review 8.  Minireview: the case for obesogens.

Authors:  Felix Grün; Bruce Blumberg
Journal:  Mol Endocrinol       Date:  2009-04-16

9.  Congenital anomalies, labor/delivery complications, maternal risk factors and their relationship with perfluorooctanoic acid (PFOA)-contaminated public drinking water.

Authors:  Lynda A Nolan; John M Nolan; Frances S Shofer; Nancy V Rodway; Edward A Emmett
Journal:  Reprod Toxicol       Date:  2009-11-06       Impact factor: 3.143

10.  Characterization of peroxisome proliferator-activated receptor alpha--independent effects of PPARalpha activators in the rodent liver: di-(2-ethylhexyl) phthalate also activates the constitutive-activated receptor.

Authors:  Hongzu Ren; Lauren M Aleksunes; Carmen Wood; Beena Vallanat; Michael H George; Curtis D Klaassen; J Christopher Corton
Journal:  Toxicol Sci       Date:  2009-10-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.